Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate Efficacy of Monotherapy of Oxcarbazepine Versus Combination of Gabapentin With Oxcarbazepine in the Management of Trigeminal Neuralgia.

NCT07625410 is registered in ClinicalTrials.gov with Rehman Medical Institute - RMI as lead sponsor.

NCT NCT07625410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07625410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate Efficacy of Monotherapy of Oxcarbazepine Versus Combination of Gabapentin With Oxcarbazepine in the Management of Trigeminal Neuralgia.
Lead sponsor
Rehman Medical Institute - RMI
Phase
Phase 2/3
Overall status
Completed
Start date
May 1, 2023
Completion date
May 1, 2024
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effectiveness of drugs was compared for treating trigeminal neuralgia, pain, pain management